Stock 000908 HUNAN JINGFENG PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hunan Jingfeng Pharmaceutical Co.,Ltd.

Equities

000908

CNE000000Y11

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 31/05/2024 am IST 		5-day change 1st Jan Change
1.8 CNY -4.76% Intraday chart for Hunan Jingfeng Pharmaceutical Co.,Ltd. -8.16% -44.44%
29/04 Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
29/04 Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Hunan Jingfeng Pharmaceutical Co.,Ltd., formerly Hunan Tianyi Science and Technology Co., Ltd, is a China-based company principally engaged in the research, development, manufacture and sale of chemical drugs, biochemical drugs and traditional Chinese patent drugs. The Company's main products includes cardio and cerebrovascular drugs, antihypertensive and hypolipidemic drugs, orthopedic drugs, anti-tumor products, endocrine drugs, digestive system drugs, antiviral drugs and anti-infective drugs, among others. The Company is also involved in commodity import and export trading, business management and consulting, as well as medical technology consulting business. The Company distributes its products in the domestic market.

Number of employees: 572

Sales per Business

CNY in Million2022Weight2023Weight Delta
Injection
57.3 %
519 61.7 % 377 57.3 % -27.39%
Solid Preparations
28.1 %
201 23.9 % 185 28.1 % -8.22%
Other
14.6 %
118 14.0 % 96 14.6 % -18.89%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
841 100.0 % 657 100.0 % -21.86%

Managers

Managers TitleAgeSince
Xiang Wu Ye FOU
 Founder 72 09/98/09
Yuan Bi BRD
 Director/Board Member 36 20/18/20
Min Chen IRC
 Investor Relations Contact 45 -
Xian Peng Ma PRN
 Corporate Officer/Principal 45 28/17/28

Members of the board

Members of the board TitleAgeSince
Xiang Wu Ye FOU
 Founder 72 09/98/09
Xiong Wen Hu BRD
 Director/Board Member 58 29/14/29
Yuan Bi BRD
 Director/Board Member 36 20/18/20
Shu Qing Xie BRD
 Director/Board Member 56 26/21/26
Xiao Qing Teng CHM
 Chairman 59 26/21/26
Ting Liu BRD
 Director/Board Member 43 24/23/24
Pei Yi Di BRD
 Director/Board Member 39 24/23/24
Shao Xian Zhong BRD
 Director/Board Member 50 28/21/28
Shen Dong Zhou BRD
 Director/Board Member 33 07/23/07

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 879,774,351 732,508,233 ( 83.26 %) 0 83.26 %

Shareholders

NameEquities%Valuation
Bohai Huijin Securities Asset Management Co. Ltd.
0.009392 %
66,400 0.009392 % 15 485 ¥
Essence Fund Co., Ltd.
0.004540 %
32,100 0.004540 % 7 486 ¥
CICC Fund Management Ltd.
0.000933 %
6,600 0.000933 % 1 539 ¥
Guotai Asset Management Co., Ltd.
0.000410 %
2,900 0.000410 % 676 ¥

Company contact information

Hunan Jingfeng Pharmaceutical Co., Ltd.

Room 9-1, 9th Floor, Building C Federation of Industry & Commerce

265701, Yantai

+86 21 6686 1001

http://www.jfyiyao.com
address Hunan Jingfeng Pharmaceutical Co.,Ltd.(000908)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
HUNAN JINGFENG PHARMACEUTICAL CO.,LTD. Stock Hunan Jingfeng Pharmaceutical Co.,Ltd.
-44.44% 22Cr
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+40.73% 74TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.83% 60TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.30% 35TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.15% 32TCr
ABBVIE INC. Stock AbbVie Inc.
+4.05% 28TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.00% 24TCr
ROCHE HOLDING AG Stock Roche Holding AG
-5.52% 21TCr
AMGEN INC. Stock Amgen Inc.
+6.17% 16TCr
PFIZER, INC. Stock Pfizer, Inc.
-0.45% 16TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 000908 Stock
  4. Company Hunan Jingfeng Pharmaceutical Co.,Ltd.